Mundipharma Extends Strategic Partnership with Kolon Life Science to Commercialise Invossa(R)-k in Saudi Arabia and United Arab Emirates
June 26, 2018SINGAPORE, June 26, 2018 /PRNewswire/ — Mundipharma has announced the extension of its strategic partnership with Kolon Life Science to market Invossa®-K in Saudi Arabia and United Arab Emirates. Invossa®-K is a treatment for osteoarthritis pain with long-term efficacy. The agreement builds on the existing co-promotion agreement between the two companies in Korea signed in April […]